APA (7th ed.) Citation

Oliveira, M., Ibanescu, R., Anstett, K., Mésplède, T., Routy, J., Robbins, M. A., . . . Group, t. M. P. H. C. S. (2018). Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir. BMC.

Chicago Style (17th ed.) Citation

Oliveira, Maureen, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, Thibault Mésplède, Jean-Pierre Routy, Marjorie A. Robbins, Bluma G. Brenner, and the Montreal Primary HIV Cohort Study Group. Selective Resistance Profiles Emerging in Patient-derived Clinical Isolates with Cabotegravir, Bictegravir, Dolutegravir, and Elvitegravir. BMC, 2018.

MLA (8th ed.) Citation

Oliveira, Maureen, et al. Selective Resistance Profiles Emerging in Patient-derived Clinical Isolates with Cabotegravir, Bictegravir, Dolutegravir, and Elvitegravir. BMC, 2018.